COLOSSUS PI Prof Rodrigo Dienstmann, MD of Vall d’Hebron Institute of Oncology, Barcelona (VHIO) presented COLOSSUS findings at two scientific meetings earlier this year.

The first, titled “Molecular subtypes of Colorectal Cancer: tumor and microenvironment interactions” was delivered at a Symphogen scientific event in Denmark on 19 March 2018. Symphogen is a clinical-stage antibody oncology-focused company with a differentiated product pipeline and significant commercial opportunities.

The second presentation was at Ulm University’s Spring Meeting in Germany on 12 April 2018. This talk was titled: “Molecular Subtypes of Colorectal Cancer: what do we need to select targeted therapies”.